Speaker(s): 

Tiffany Tang, PharmD, Resident, Geisinger - has nothing to disclose 

Evan Liddington, Resident, PharmD, Geisinger - has nothing to disclose 

Moderator(s): 

Sarah Hale, Pharm.D., BCPPS. Director of Pharmacy, Geisinger  - has nothing to disclose 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Evaluate the efficacy and safety of tranexamic acid in managing upper gastrointestinal bleeding in patients with cirrhotic patients. ​
• Discuss the clinical implications of these findings on patient management and practice.
• Analyze recent evidence on antibiotic treatment durations in bloodstream infections.
• Differentiate between treatments in pathogen-specific causes of bacteremia.
• Determine pharmacists’ preferences on treatment durations for bloodstream infections.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Sarah F. Hale, PharmD, Brain Simpkins, PharmD, Jessica Milheim, CPhT, and Tiffany Tang, PharmD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None